The familial chylomicronemia syndrome

被引：113

作者：

Santamarina-Fojo, S ^{[1
]}

机构：

[1] NHLBI, Mol Biol Sect, Mol Dis Branch, NIH, Bethesda, MD 20892 USA

来源：

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 1998年 / 27卷 / 03期

关键词：

D O I：

10.1016/S0889-8529(05)70025-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The chylomicronemia syndrome is a disorder characterized by severe hypertriglyceridemia and fasting chylomicronemia. Genetic causes of the syndrome are rare and include deficiency of lipoprotein lipase (LPL), apolipoprotein C-II, and familial inhibitor of LPL. Patients with familial forms of hypertriglyceridemia in combination with secondary acquired disorders account for most individuals presenting with chylomicronemia. The clinical manifestations-lipid and other biochemical abnormalities-as well as treatment options for chylomicronemic patients are discussed.

引用

页码：551 / +

页数：18

共 146 条

[1] FAMILIAL CHYLOMICRONEMIA (TYPE-I HYPERLIPOPROTEINEMIA) DUE TO A SINGLE MISSENSE MUTATION IN THE LIPOPROTEIN-LIPASE GENE [J].

AMEIS, D ;

KOBAYASHI, J ;

DAVIS, RC ;

BENZEEV, O ;

MALLOY, MJ ;

KANE, JP ;

LEE, G ;

WONG, H ;

HAVEL, RJ ;

SCHOTZ, MC .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (04) :1165-1170

[2] RELATIONSHIP BETWEEN TRIGLYCERIDE-RICH LIPOPROTEIN (CHYLOMICRONS AND VLDL) AND HDL2 AND HDL3 IN THE POST-PRANDIAL PHASE IN HUMANS [J].

BAGGIO, G ;

FELLIN, R ;

BAIOCCHI, MR ;

MARTINI, S ;

BALDO, G ;

MANZATO, E ;

CREPALDI, G .

ATHEROSCLEROSIS, 1980, 37 (02) :271-276

[3] APOLIPOPROTEIN C-II DEFICIENCY SYNDROME - CLINICAL-FEATURES, LIPOPROTEIN CHARACTERIZATION, LIPASE ACTIVITY, AND CORRECTION OF HYPERTRIGLYCERIDEMIA AFTER APOLIPOPROTEIN C-II ADMINISTRATION IN 2 AFFECTED PATIENTS [J].

BAGGIO, G ;

MANZATO, E ;

GABELLI, C ;

FELLIN, R ;

MARTINI, S ;

ENZI, GB ;

VERLATO, F ;

BAIOCCHI, MR ;

SPRECHER, DL ;

KASHYAP, ML ;

BREWER, HB ;

CREPALDI, G .

JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) :520-527

[4] LIPOPROTEIN-LIPASE BETHESDA - A SINGLE AMINO-ACID SUBSTITUTION (ALA-176-]THR) LEADS TO ABNORMAL HEPARIN BINDING AND LOSS OF ENZYMATIC-ACTIVITY [J].

BEG, OU ;

MENG, MS ;

SKARLATOS, SI ;

PREVIATO, L ;

BRUNZELL, JD ;

BREWER, HB ;

FOJO, SS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) :3474-3478

[5] HOMOLOGY OF LIPOPROTEIN-LIPASE TO PANCREATIC LIPASE [J].

BENAVRAM, CM ;

BENZEEV, O ;

LEE, TD ;

HAAGA, K ;

SHIVELY, JE ;

GOERS, J ;

PEDERSEN, ME ;

REEVE, JR ;

SCHOTZ, MC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (12) :4185-4189

[6]

Benlian P, 1996, AM J HUM GENET, V59, P431

[7] Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene [J].

Benlian, P ;

DeGennes, JL ;

Foubert, L ;

Zhang, HF ;

Gagne, SE ;

Hayden, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (12) :848-854

[8]

BENLIAN P, 1991, ARTERIOSCLER THROMB, V11, P1465

[9]

BERGERON J, 1992, CLIN GENET, V41, P206

[10]

Bierman E L, 1970, Trans Assoc Am Physicians, V83, P211

← 1 2 3 4 5 6 7 8 9 10 →